Moleculin Biotech (NASDAQ:MBRX) Receives New Coverage from Analysts at StockNews.com
StockNews.com began coverage on shares of Moleculin Biotech (NASDAQ:MBRX – Free Report) in a report published on Wednesday morning. The brokerage issued a sell rating on the stock. Moleculin Biotech Stock Performance Shares of Moleculin Biotech stock opened at $0.61 on Wednesday. The business’s 50 day moving average price is $0.51 and its 200 day […]
More Stories
Palisade Asset Management LLC Acquires 133 Shares of Merck & Co., Inc. (NYSE:MRK)
Palisade Asset Management LLC raised its holdings in Merck & Co., Inc. (NYSE:MRK – Free Report) by 0.5% during the...
L3Harris Technologies, Inc. (NYSE:LHX) Shares Sold by Palisade Asset Management LLC
Palisade Asset Management LLC reduced its position in L3Harris Technologies, Inc. (NYSE:LHX – Free Report) by 1.0% in the 3rd...
Certified Advisory Corp Has $1.70 Million Stock Holdings in QUALCOMM Incorporated (NASDAQ:QCOM)
Certified Advisory Corp lifted its position in shares of QUALCOMM Incorporated (NASDAQ:QCOM – Free Report) by 8.5% in the third...
Cerity Partners LLC Has $91.47 Million Stake in Caterpillar Inc. (NYSE:CAT)
Cerity Partners LLC raised its holdings in Caterpillar Inc. (NYSE:CAT – Free Report) by 10.3% during the 3rd quarter, HoldingsChannel...
Advisors Asset Management Inc. Purchases 13,689 Shares of NIKE, Inc. (NYSE:NKE)
Advisors Asset Management Inc. raised its position in NIKE, Inc. (NYSE:NKE – Free Report) by 39.6% in the 3rd quarter,...
Cerity Partners LLC Has $350.78 Million Stock Position in iShares Russell 1000 Growth ETF (NYSEARCA:IWF)
Cerity Partners LLC raised its holdings in iShares Russell 1000 Growth ETF (NYSEARCA:IWF – Free Report) by 13.2% during the...